# Chimera Investment Corp: financial statements, quarterly

CIM · NYSE · CIK 1409493 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cim.md) · [Financials](/companies/cim/financials.md) · [Filings](/companies/cim/filings.md) · [Insiders](/companies/cim/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cim/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [132](/filings/0001628280-24-007962.md) | [127](/filings/0001628280-24-007962.md) | [121](/filings/0001628280-24-022269.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.1](/filings/0001628280-24-045708.md) | [0.0 d](/filings/0001409493-26-000017.md) | [0.0](/filings/0001628280-25-023813.md) | [0.0](/filings/0001628280-25-038345.md) | [0.0](/filings/0001409493-25-000028.md) | [(0.0) d](/filings/0001409493-26-000017.md) | [1.8](/filings/0001409493-26-000037.md) | [0.4](/filings/0001409493-26-000050.md) | [0.3](/filings/0001409493-25-000028.md) | [(0.1) d](/filings/0001409493-26-000017.md) | [(2.1)](/filings/0001409493-26-000037.md) | [(0.3)](/filings/0001409493-26-000050.md) |
| Net income | $m | [2.2](/filings/0001628280-25-006426.md) | [30.5](/filings/0001628280-25-006426.md) | [129](/filings/0001409493-26-000017.md) | [56.7](/filings/0001409493-26-000017.md) | [136](/filings/0001409493-26-000017.md) | [(147)](/filings/0001409493-26-000017.md) | [167](/filings/0001409493-26-000037.md) | [35.5](/filings/0001409493-26-000050.md) | [(0.6)](/filings/0001409493-26-000017.md) | [28.3](/filings/0001409493-26-000017.md) | [(43.9)](/filings/0001409493-26-000037.md) | [17.4](/filings/0001409493-26-000050.md) |
| Diluted EPS | $ per share | [(0.22)](/filings/0001628280-24-045708.md) | not reported | [1.36](/filings/0001628280-25-023813.md) | [0.41](/filings/0001628280-25-038345.md) | [1.39](/filings/0001409493-25-000028.md) | not reported | [1.77](/filings/0001409493-26-000037.md) | [0.17](/filings/0001409493-26-000050.md) | [(0.27)](/filings/0001409493-25-000028.md) | not reported | [(0.78)](/filings/0001409493-26-000037.md) | [(0.05)](/filings/0001409493-26-000050.md) |
| Basic EPS | $ per share | [(0.22)](/filings/0001628280-25-006426.md) | [0.16](/filings/0001628280-25-006426.md) | [1.37](/filings/0001409493-26-000017.md) | [0.42](/filings/0001409493-26-000017.md) | [1.41](/filings/0001409493-26-000017.md) | [(2.07)](/filings/0001409493-26-000017.md) | [1.79](/filings/0001409493-26-000037.md) | [0.17](/filings/0001409493-26-000050.md) | [(0.27)](/filings/0001409493-26-000017.md) | [0.08](/filings/0001409493-26-000017.md) | [(0.78)](/filings/0001409493-26-000037.md) | [(0.05)](/filings/0001409493-26-000050.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.1](/filings/0001628280-23-036403.md) | [0.2](/filings/0001628280-25-006426.md) | [0.2](/filings/0001628280-24-022269.md) | [0.2](/filings/0001628280-24-035631.md) | [0.1](/filings/0001628280-24-045708.md) | [0.1](/filings/0001409493-26-000017.md) | [0.3](/filings/0001628280-25-023813.md) | [0.3](/filings/0001628280-25-038345.md) | [0.5](/filings/0001409493-25-000028.md) | [0.3](/filings/0001409493-26-000050.md) | [0.5](/filings/0001409493-26-000037.md) | [0.4](/filings/0001409493-26-000050.md) |
| Total assets | $bn | [12.9](/filings/0001628280-23-036403.md) | [12.9](/filings/0001628280-25-006426.md) | [12.5](/filings/0001628280-24-022269.md) | [13.1](/filings/0001628280-24-035631.md) | [13.7](/filings/0001628280-24-045708.md) | [13.1](/filings/0001409493-26-000017.md) | [13.2](/filings/0001628280-25-023813.md) | [14.9](/filings/0001628280-25-038345.md) | [15.1](/filings/0001409493-25-000028.md) | [15.8](/filings/0001409493-26-000050.md) | [16.0](/filings/0001409493-26-000037.md) | [16.0](/filings/0001409493-26-000050.md) |
| Total liabilities | $bn | [10.4](/filings/0001628280-23-036403.md) | [10.4](/filings/0001628280-25-006426.md) | [9.9](/filings/0001628280-24-022269.md) | [10.5](/filings/0001628280-24-035631.md) | [11.0](/filings/0001628280-24-045708.md) | [10.6](/filings/0001409493-26-000017.md) | [10.6](/filings/0001628280-25-023813.md) | [12.2](/filings/0001628280-25-038345.md) | [12.5](/filings/0001409493-25-000028.md) | [13.2](/filings/0001409493-26-000050.md) | [13.5](/filings/0001409493-26-000037.md) | [13.6](/filings/0001409493-26-000050.md) |
| Long-term debt | $bn | not reported | [0.0](/filings/0001628280-25-006426.md) | not reported | [0.1](/filings/0001628280-24-035631.md) | [0.1](/filings/0001628280-24-045708.md) | [0.1](/filings/0001409493-26-000017.md) | [0.1](/filings/0001628280-25-023813.md) | [0.1](/filings/0001628280-25-038345.md) | [0.3](/filings/0001409493-25-000028.md) | [0.3](/filings/0001409493-26-000050.md) | [0.3](/filings/0001409493-26-000037.md) | [0.3](/filings/0001409493-26-000050.md) |
| Shareholders' equity | $bn | [2.5](/filings/0001628280-24-045708.md) | [2.6](/filings/0001409493-26-000017.md) | [2.6](/filings/0001628280-25-038345.md) | [2.6](/filings/0001409493-25-000028.md) | [2.7](/filings/0001409493-25-000028.md) | [2.5](/filings/0001409493-26-000050.md) | [2.6](/filings/0001409493-26-000050.md) | [2.6](/filings/0001409493-26-000050.md) | [2.6](/filings/0001409493-25-000028.md) | [2.6](/filings/0001409493-26-000050.md) | [2.5](/filings/0001409493-26-000050.md) | [2.4](/filings/0001409493-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [44.7 d](/filings/0001628280-24-045708.md) | [31.3 d](/filings/0001409493-26-000017.md) | [57.3](/filings/0001628280-25-023813.md) | [69.0 d](/filings/0001628280-25-038345.md) | [41.4 d](/filings/0001409493-25-000028.md) | [38.0 d](/filings/0001409493-26-000017.md) | [48.8](/filings/0001409493-26-000037.md) | [(7.4) d](/filings/0001409493-26-000050.md) | [(137) d](/filings/0001409493-25-000028.md) | [(153) d](/filings/0001409493-26-000017.md) | [243](/filings/0001409493-26-000037.md) | [(339) d](/filings/0001409493-26-000050.md) |
| Dividends paid | $m | [44.0 d](/filings/0001628280-24-045708.md) | [42.7 d](/filings/0001409493-26-000017.md) | [26.8](/filings/0001628280-25-023813.md) | [27.2 d](/filings/0001628280-25-038345.md) | [34.9 d](/filings/0001409493-25-000028.md) | [30.1 d](/filings/0001409493-26-000017.md) | [30.6](/filings/0001409493-26-000037.md) | [30.2 d](/filings/0001409493-26-000050.md) | [30.0 d](/filings/0001409493-25-000028.md) | [31.9 d](/filings/0001409493-26-000017.md) | [32.4](/filings/0001409493-26-000037.md) | [37.7 d](/filings/0001409493-26-000050.md) |
| Share repurchases | $m | [6.9 d](/filings/0001628280-24-045708.md) | [0.0 d](/filings/0001409493-26-000017.md) | not reported | not reported | [0.0 d](/filings/0001628280-24-045708.md) | [0.0 d](/filings/0001409493-26-000017.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [232](/filings/0001628280-23-036403.md) | [235](/filings/0001628280-24-022269.md) | [78.0](/filings/0001628280-24-035631.md) | [75.6](/filings/0001628280-24-045708.md) | [81.7](/filings/0001628280-25-023813.md) | [82.3](/filings/0001628280-25-038345.md) | [81.9](/filings/0001409493-25-000028.md) | [82.4](/filings/0001409493-26-000037.md) | [82.6](/filings/0001409493-26-000050.md) | [81.5](/filings/0001409493-25-000028.md) | [83.7](/filings/0001409493-26-000037.md) | [83.8](/filings/0001409493-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 83,711,818 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001409493-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.